Xeris Biopharma Holdings, Inc. XERS Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s operating margin?
- Xeris Biopharma Holdings, Inc. (XERS) reported operating margin of 11.4% in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s operating margin changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s operating margin increased by 205.0% year-over-year, from -10.9% to 11.4%.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s operating margin?
- Over 4 years (2021 to 2025), Xeris Biopharma Holdings, Inc.'s operating margin has grown at a -56.2% compound annual growth rate (CAGR), from -232.2% to 8.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.